Sertraline, a selective serotonin reuptake inhibitor (SSRI), is sometimes used off-label for Cluster Headache management, potentially modulating serotonergic neurotransmission to reduce headache frequency and intensity. Its mechanism likely involves altering serotonin signaling in pain pathways and potentially influencing hypothalamic and limbic system regulation of pain perception and autonomic responses.